Carl Zeiss Medite I
AFX
EUR
STOCK MARKET:
ETR
Open
 
...
Large gap with delayed quotes
Last quote
12/27/2024 - 13:55:49
Bid
12/27/2024 - 13:56:16
Bid
Volume
Ask
12/27/2024 - 13:55:51
Ask
Volume
47.22
+0.84 ( +1.81% )
47.22
75
47.26
29
More information
Analysis by TheScreener
24.12.2024
Evaluation Slightly negative  
Interest Very weak  
Sensibility High  
Analysis date: 24.12.2024
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 13.12.2024.
Interest
  Very weak
Very weak interest since 17.12.2024.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 17.12.2024 at a price of 47.76.
Evaluation
  Strongly undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is strongly undervalued.
MT Tech Trend
  Negative
 
The forty day Medium Term Technical Trend is negative since 13.12.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is .
4wk Rel Perf
  -18.71%
 
The four week relative underperformance versus STOXX600 is 18.71%.
Sensibility
  High
The stock has been on the high-sensitivity level since 13.12.2024.
Bear Market Factor
  High
On average, the stock has a tendency to amplify the drops in the index by 1.10%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.54%.
Mkt Cap in $bn
  4.31
With a market capitalization between $2 & $8bn, CARL ZEISS MEDITEC is considered a mid-cap stock.
G/PE Ratio
  1.02
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  17.72
The estimated PE is for the year 2027.
LT Growth
  16.46%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  13
Over the last seven weeks, an average of 13 analysts provided earnings per share estimates.
Dividend Yield
  1.57%
The twelve month estimated dividend yield represents 27.77% of earnings forecasts.
Beta
  133
For 1% of index variation, the stock varies on average by 1.33%.
Correlation
  0.30
Stock movements are strongly independent of index variations.
Value at Risk
  11.14
The value at risk is estimated at EUR 11.14. The risk is therefore 24.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  16.04.2004